Epizyme, Inc. - stock earnings
Stock symbol EPZM is outdated, potentially delisted? Maybe it is available on other exchange?
EPZM Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q1 | -55.5 million USD | 8.7 million USD |
| 2021Q4 | -50.7 million USD | 11.6 million USD |
| 2021Q3 | -65.8 million USD | 5.2 million USD |
| 2021Q2 | -64.4 million USD | 13.0 million USD |
| 2021Q1 | -70.3 million USD | 7.6 million USD |
| 2020Q4 | -66.2 million USD | 8.4 million USD |
| 2020Q3 | -56.1 million USD | 3.6 million USD |
EPZM Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -251.1 million USD | 37.4 million USD |
| 2020 | -231.7 million USD | 15.8 million USD |
| 2019 | -170.3 million USD | 23.8 million USD |
| 2018 | -123.6 million USD | 21.7 million USD |
| 2017 | -134.3 million USD | 10.0 million USD |
EPZM
Price: $1.47
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.21 USD
P/E Ratio: -5.27
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 5.1 million
Ebitda: -37.6 millionMarket Capitalization: 247.5 million